:: IC :: Infection & Chemotherapy
pISSN 2093-2340   eISSN 2092-6448
Indexed in ESCI, PubMed, Scopus, DOAJ and more
Open Access, Peer-reviewed
    Infect Chemother. 2009 Nov-Dec;41(6):349-354. Korean.
    Published online Dec 31, 2009.
    https://doi.org/10.3947/ic.2009.41.6.349
    Copyright © 2009 The Korean Society of Infectious Diseases; The Korean Society for Chemotherapy
    Original Article

    Influenza Vaccine Coverage Rate and Related Factors on Pregnant Women

    Mi-Jung Kim, M.D.,1 Seung-Youn Lee, M.D.,1 Kwang-Soo Lee, M.D.,1 Aerum Kim, M.D.,1 Dongwook Son, M.D.,1 Moon-Hyun Chung, M.D.,1 Shin-Goo Park, M.D.,2 Ji-Hyun Park, M.D.,3 Byung-Ik Lee, M.D.,3 and Jin-Soo Lee, M.D.1
      • 1Department of Internal Medicine, School of Medicine, Inha University, Incheon, Korea.
      • 2Department of Occupational Medicine, School of Medicine, Inha University, Incheon, Korea.
      • 3Department of Obstetrics and Gynecology, School of Medicine, Inha University, Incheon, Korea.
    • Corresponding author: Jin-Soo Lee, M.D. Department of Internal Medicine, School of Medicine, Inha University, 7-206, Sinheung-dong 3-ga, Jung-gu, Incheon 400-711, Korea. Tel: +82-32-890-3616, Fax: +82-32-882-6578, Email: ljinsoo@inha.ac.kr
    Received October 13, 2009; Accepted September 17, 2009.

    This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

    Abstract

    Background

    During seasonal influenza epidemics and previous pandemics, pregnant women have been at increased risk for complications related to influenza infection. Although influenza vaccination has been widely recommended to pregnant women and immunocompromised hosts, the vaccination rate is presumed to be low in pregnant women. This study was aimed to evaluate the vaccination rate and factors associated with Influenza vaccination among pregnant women, who are at high risk for developing complications from the influenza.

    Materials and Methods

    This study was carried out by telephone survey from April, 2007 to August, 2007. Women who were in their second trimester of pregnancy or above,- during October, 2006 and February, 2007, the recommended vaccination period, and had given birth at Inha University Hospital were selected as the study population. Immunization status, general understanding, and factors associated with vaccination were evaluated.

    Results

    Among a total of 506 eligible pregnant women, 227 (44.8%) responded to the questionnaires. The influenza vaccination rate among the pregnant women was only 4% (9/227). Major reasons for not receiving vaccination were first, not awaring the necessity of immunization during pregnancy (48.5%, 110/227) and second, misunderstanding that it is prohibited during pregnancy (36.1%, 82/227). The major factors that influenced the compliance of vaccination were correct understanding and doctor's recommendation on the influenza immunization during pregnancy.

    Conclusions

    The influenza vaccine coverage on pregnant women was very low and the awareness of influenza vaccination during pregnancy in general was inaccurate. Shift in perception is required and this can be achieved by educating the pregnant women on the safety and efficacy of vaccination. In addition, doctors' active encouragement to vaccination is highly recommended.

    Keywords
    Influenza vaccine; Immunization rate; Pregnant women; Vaccination

    Tables

    Table 1
    The Questionnaire on the Understanding of Influenza Vaccination

    Table 2
    The Major Reasons for Not Having Received Vaccination

    Table 3
    The Associated Factors to Receive Vnaccination

    References

      1. Meier CR, Napalkov PN, Wegmüller Y, Jefferson T, Jick H. Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom. Eur J Clin Microbiol Infect Dis 2000;19:834–842.
      1. Sprenger MJ, Mulder PG, Beyer WE, Van Strik R, Masurel N. Impact of influenza on mortality in relation to age and underlying disease, 1967-1989. Int J Epidemiol 1993;22:334–340.
      1. Nichol KL, Lind A, Margolis KL, Murdoch M, McFadden R, Hauge M, Magnan S, Drake M. The effectiveness of vaccination against influenza in healthy, working adults. N Engl J Med 1995;333:889–893.
      1. ridges CB, Thompson WW, Meltzer MI, Reeve GR, Talamonti WJ, Cox NJ, Lilac HA, Hall H, Klimov A, Fukuda K. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial. JAMA 2000;284:1655–1663.
      1. Jackson LA, Jackson ML, Nelson JC, Neuzil KM, Weiss NS. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol 2006;35:337–344.
      1. Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 2007;7:658–666.
      1. Harris JW. Influenza occurring in pregnant women: a statistical study of thirteen hundred and fifty cases. JAMA 1919;72:978–980.
      1. Widelock D, Csizmas L, Klein S. Influenza, pregnancy, and fetal outcome. Public Health Rep 1963;78:1–11.
      1. Freeman DW, Barno A. Deaths from Asian influenza associated with pregnancy. Am J Obstet Gynecol 1959;78:1172–1175.
      1. Naleway AL, Smith WJ, Mullooly JP. Delivering influenza vaccine to pregnant women. Epidemiol Rev 2006;28:47–53.
      1. Hardy JM, Azarowicz EN, Mannini A, Medearis DN Jr, Cooke RE. The effect of Asian influenza on the outcome of pregnancy, Baltimore, 1957-1958. Am J Public Health Nations Health 1961;51:1182–1188.
      1. Rasmussen SA, Jamieson DJ, Bresee JS. Pandemic Influenza and Pregnant Women. Emerg Infect Dis 2008;14:95–100.
      1. Kee SY, Lee JS, Cheong HJ, Chun BC, Song JY, Choi WS, Jo YM, Seo YB, Kim WJ. Influenza vaccine coverage rates and perceptions on vaccination in South Korea. J Infect 2007;55:273–281.
      1. Lim WS, Macfarlane JT, Colthorpe CL. Treatment of community-acquired lower respiratory tract infections during pregnancy. Am J Respir Med 2003;2:221–233.
      1. Mullooly JP, Barker WH, Nolan TF Jr. Risk of acute respiratory disease among pregnant women during influenza A epidemics. Public Health Rep 1986;101:205–211.
      1. Dodds L, McNeil SA, Fell DB, Allen VM, Coombs A, Scott J, MacDonald N. Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women. CMAJ 2007;176:463–468.
      1. Lu P, Bridges CB, Euler GL, Singleton JA. Influenza vaccination of recommended adult populations, U.S., 1989-2005. Vaccine 2008;26:1786–1793.
      1. Holm MV, Blank PR, Szucs TD. Trends in influenza vaccination coverage rates in Germany over five seasons from 2001 to 2006. BMC Infect Dis 2007;7:144.
      1. Zhou W, Pool V, Iskander JK, English-Bullard R, Ball R, Wise RP, Haber P, Pless RP, Mootrey G, Ellenberg SS, Braun MM, Chen RT. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001. MMWR Surveill Summ 2003;52:1–24.
      1. Lasky T, Terracciano GJ, Magder L, Koski CL, Ballesteros M, Nash D, Clark S, Haber P, Stolley PD, Schonberger LB, Chen RT. The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines. New Engl J Med 1998;339:1797–1802.
      1. Munoz FM, Greisinger AJ, Wehmanen OA, Mouzoon ME, Hoyle JC, Smith FA, Glezen WP. Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol 2005;192:1098–1106.
      1. Sumaya CV, Gibbs RS. Immunization of pregnant women with influenza A/New Jersey/76 virus vaccine: reactogenicity and immunogenicity in mother and infant. J Infect Dis 1979;140:141–146.
      1. Englund JA, Mbawuike IN, Hammill H, Holleman MC, Baxter BD, Glezen WP. Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants. J Infect Dis 1993;168:647–656.
      1. Puck JM, Glezen WP, Frank AL, Six HR. Protection of infants from infection with influenza A virus by transplacentally acquired antibody. J Infect Dis 1980;142:844–849.
      1. Lanternier F, Henegar C, Mouthon L, Blanche P, Guillevin L, Launay O. Low influenza-vaccination rate among adults receiving immunosuppressive therapy for systemic inflammatory disease. Ann Rheum Dis 2008;67:1047.
      1. Zimmerman RK, Nowalk MP, Bardella IJ, Fine MJ, Janosky JE, Santibanez TA, Wilson SA, Raymund M. Physician and practice factors related to influenza vaccination among the elderly. Am J Prev Med 2004;26:1–10.
      1. Nichol KL, Mac Donald R, Hauge M. Factors associated with influenza and pneumococcal vaccination behavior among high-risk adults. J Gen Intern Med 1996;11:673–677.
    Cited by
    Crossref 13
    Google Scholar 
    MeSH Terms
    Compliance
    Female
    Humans
    Immunization
    Immunocompromised Host
    Influenza Vaccines
    Influenza, Human
    Pandemics
    Parturition
    Pregnancy
    Pregnancy Trimester, Second
    Pregnant Women
    Seasons
    Surveys and Questionnaires
    Telephone
    Vaccination
    Metrics
    Share
    Tables
    slide
    slide
    slide

    1 / 3

    PERMALINK
    -